IL130967A0 - Freeze-dried composition of bone morphogenetic protein human mp52 - Google Patents

Freeze-dried composition of bone morphogenetic protein human mp52

Info

Publication number: IL130967A0
Authority: IL; Israel
Prior art keywords: freeze; bone morphogenetic; morphogenetic protein; dried composition; protein human
Prior art date: 1997-01-30

Application number

IL13096798A

Other languages

English (en)

Original Assignee

Hoechst Marion Roussel Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-30

Filing date

1998-01-29

Publication date

2001-01-28

1998-01-29 Application filed by Hoechst Marion Roussel Ltd filed Critical Hoechst Marion Roussel Ltd

2001-01-28 Publication of IL130967A0 publication Critical patent/IL130967A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Orthopedic Medicine & Surgery (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IL13096798A 1997-01-30 1998-01-29 Freeze-dried composition of bone morphogenetic protein human mp52 IL130967A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP1634997		1997-01-30
PCT/JP1998/000371 WO1998033514A1 (en)	1997-01-30	1998-01-29	Freeze-dried composition of bone morphogenetic protein human mp52

Publications (1)

Publication Number	Publication Date
IL130967A0 true IL130967A0 (en)	2001-01-28

Family

ID=11913900

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL13096798A IL130967A0 (en)	1997-01-30	1998-01-29	Freeze-dried composition of bone morphogenetic protein human mp52
IL130967A IL130967A (en)	1997-01-30	1999-07-15	Freeze-dried preparation of human morphogenetic MP52 bone protein

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL130967A IL130967A (en)	1997-01-30	1999-07-15	Freeze-dried preparation of human morphogenetic MP52 bone protein

Country Status (22)

Country	Link
EP (1)	EP0972520B9 (xx)
JP (1)	JP4209948B2 (xx)
KR (1)	KR100548107B1 (xx)
CN (1)	CN1152712C (xx)
AP (1)	AP983A (xx)
AT (1)	ATE302021T1 (xx)
AU (1)	AU737595B2 (xx)
BR (1)	BR9807537B1 (xx)
CA (1)	CA2278546C (xx)
DE (1)	DE69831223T9 (xx)
DK (1)	DK0972520T3 (xx)
EA (1)	EA001579B1 (xx)
ES (1)	ES2244043T3 (xx)
HU (1)	HU226554B1 (xx)
IL (2)	IL130967A0 (xx)
NO (1)	NO322334B1 (xx)
NZ (1)	NZ336509A (xx)
PL (1)	PL189381B1 (xx)
RS (1)	RS49691B (xx)
SI (1)	SI0972520T1 (xx)
TR (1)	TR199901832T2 (xx)
WO (1)	WO1998033514A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6267798A (en) †	1997-02-07	1998-08-26	Stryker Corporation	Matrix-free osteogenic devices, implants and methods of use thereof
EP1434569A1 (en) *	2001-10-09	2004-07-07	CellFactors plc	Therapeutic biological product and method for formation of new vascularised bone
DK1448246T4 (en)	2001-11-19	2015-12-21	Scil Technology Gmbh	Homogeneously coated device with osteoinductive and osteoconductive properties
AU2003253049A1 (en)	2002-09-10	2004-04-30	Scil Technology Gmbh	Metal implant coated under reduced oxygen concentration with osteoinductive protein
WO2005011739A1 (en) *	2003-08-05	2005-02-10	Fuji Photo Film B.V.	Use of recombinant or synthetic gelatin as a stabiliser in vaccines
EP1685160A1 (en) *	2003-11-10	2006-08-02	Arriva-Prometic Inc.	Dry recombinant human alpha 1-antitrypsin formulation
DK1737734T3 (da)	2004-03-10	2010-11-08	Scil Technology Gmbh	Overtrukne implantater, deres fremstilling og anvendelse deraf
US10360287B2 (en)	2015-05-22	2019-07-23	Microsoft Technology Licensing, Llc	Unified messaging platform and interface for providing user callouts
US20160344677A1 (en)	2015-05-22	2016-11-24	Microsoft Technology Licensing, Llc	Unified messaging platform for providing interactive semantic objects

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0080879B1 (en) *	1981-11-28	1986-10-01	Sunstar Kabushiki Kaisha	Pharmaceutical composition containing interferon in stable state
US5037644A (en) *	1986-10-27	1991-08-06	Cetus Corporation	Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
JP3351525B2 (ja) *	1991-06-21	2002-11-25	ジェネティックス・インスティテュート・インコーポレイテッド	骨形成性蛋白医薬処方物
JP2966592B2 (ja) *	1991-07-20	1999-10-25	萩原義秀	安定化されたヒトモノクローナル抗体製剤
CZ287715B6 (en) *	1992-02-12	2001-01-17	Bioph Biotech Entw Pharm Gmbh	DNA sequence, recombinant DNA molecule containing thereof, process for preparing protein from the group of TGF-beta substances, pharmaceutical preparation containing such protein, antibody or fragment thereof and its use
CA2093836A1 (en) *	1992-04-24	1993-10-25	Wayne Gombotz	Biodegradable tgf-.beta. delivery system for bone regeneration
DE4239877C1 (de) *	1992-11-27	1994-03-17	Boehringer Ingelheim Int	Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
ES2166841T3 (es) *	1995-03-21	2002-05-01	Applied Research Systems	Formulaciones liquidas de hcg.
AU704515C (en) *	1995-04-19	2002-03-28	Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh	Novel protein and process for producing the same

1998
- 1998-01-29 EA EA199900694A patent/EA001579B1/ru not_active IP Right Cessation
- 1998-01-29 CA CA002278546A patent/CA2278546C/en not_active Expired - Fee Related
- 1998-01-29 IL IL13096798A patent/IL130967A0/xx active IP Right Grant
- 1998-01-29 NZ NZ336509A patent/NZ336509A/xx not_active IP Right Cessation
- 1998-01-29 TR TR1999/01832T patent/TR199901832T2/xx unknown
- 1998-01-29 WO PCT/JP1998/000371 patent/WO1998033514A1/ja not_active Ceased
- 1998-01-29 ES ES98901044T patent/ES2244043T3/es not_active Expired - Lifetime
- 1998-01-29 CN CNB988019841A patent/CN1152712C/zh not_active Expired - Fee Related
- 1998-01-29 RS YUP-349/99A patent/RS49691B/sr unknown
- 1998-01-29 JP JP53271798A patent/JP4209948B2/ja not_active Expired - Fee Related
- 1998-01-29 KR KR1019997006833A patent/KR100548107B1/ko not_active Expired - Fee Related
- 1998-01-29 EP EP98901044A patent/EP0972520B9/en not_active Expired - Lifetime
- 1998-01-29 DE DE69831223T patent/DE69831223T9/de active Active
- 1998-01-29 DK DK98901044T patent/DK0972520T3/da active
- 1998-01-29 HU HU0002386A patent/HU226554B1/hu not_active IP Right Cessation
- 1998-01-29 AU AU56791/98A patent/AU737595B2/en not_active Ceased
- 1998-01-29 BR BRPI9807537-3A patent/BR9807537B1/pt not_active IP Right Cessation
- 1998-01-29 PL PL98334852A patent/PL189381B1/pl not_active IP Right Cessation
- 1998-01-29 AP APAP/P/1999/001602A patent/AP983A/en active
- 1998-01-29 AT AT98901044T patent/ATE302021T1/de active
- 1998-01-29 SI SI9830798T patent/SI0972520T1/sl unknown
1999
- 1999-07-15 IL IL130967A patent/IL130967A/en not_active IP Right Cessation
- 1999-07-29 NO NO19993702A patent/NO322334B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUP0002386A3 (en)	2002-09-30
PL334852A1 (en)	2000-03-27
EP0972520B9 (en)	2006-03-22
DE69831223T9 (de)	2006-12-07
CN1152712C (zh)	2004-06-09
WO1998033514A1 (en)	1998-08-06
AU5679198A (en)	1998-08-25
IL130967A (en)	2006-12-10
DE69831223T2 (de)	2006-02-16
EA001579B1 (ru)	2001-06-25
KR20000070586A (ko)	2000-11-25
NO322334B1 (no)	2006-09-18
CA2278546A1 (en)	1998-08-06
BR9807537B1 (pt)	2009-01-13
EA199900694A1 (ru)	2000-04-24
YU34999A (sh)	2002-08-12
ATE302021T1 (de)	2005-09-15
NO993702D0 (no)	1999-07-29
BR9807537A (pt)	2000-03-21
SI0972520T1 (sl)	2006-02-28
AU737595B2 (en)	2001-08-23
PL189381B1 (pl)	2005-07-29
DE69831223D1 (de)	2005-09-22
KR100548107B1 (ko)	2006-02-02
EP0972520A1 (en)	2000-01-19
CN1244127A (zh)	2000-02-09
RS49691B (sr)	2007-12-31
EP0972520B1 (en)	2005-08-17
JP4209948B2 (ja)	2009-01-14
TR199901832T2 (xx)	1999-12-21
NO993702L (no)	1999-09-29
ES2244043T3 (es)	2005-12-01
HU226554B1 (en)	2009-03-30
HUP0002386A2 (hu)	2000-11-28
AP983A (en)	2001-07-16
NZ336509A (en)	2001-03-30
EP0972520A4 (en)	2002-11-05
AP9901602A0 (en)	1999-09-30
CA2278546C (en)	2008-04-01
DK0972520T3 (da)	2005-12-19

Publication	Publication Date	Title
AU3866097A (en)	1998-03-06	Naphtholactams and lactones as bone morphogenetic protein active agents
EG22500A (en)	2003-03-31	Use of an encapsulated bioactive composition
EP1047442A4 (en)	2002-01-02	BONE MORPHOGENETIC PROTEINS AND THEIR USE IN BONE GROWTH
HUP9902187A3 (en)	2000-01-28	Diaphysial cortical dowel
ZA989461B (en)	1999-04-21	Methods and compositions for the treatment of autoimmune disease using heat shock proteins
HUP9802556A3 (en)	1999-04-28	Use of bone morphogenetic protein (bmp) for regeneration of functional connection of bone and tendon or ligament
PL339463A1 (en)	2000-12-18	April - novel protein of growth promoting action
EP1039801A4 (en)	2003-03-26	207 HUMAN SECRETED PROTEINS
EP1000084A4 (en)	2003-03-26	123 PROTEIN SEPARATED BY HUMAN
FI960809L (fi)	1996-02-22	Hermoregeneraatio käyttäen ihmisen luun morfogeneettisiä proteiineja
FI962349L (fi)	1996-07-16	Luun morfogeneettisten proteiinien mutantit
EP0950665A4 (en)	2004-05-06	PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
EP1040117A4 (en)	2005-03-09	110 HUMAN SECRETATED PROTEINS
PL330416A1 (en)	1999-05-10	Method of and composition for lighting up human hair
EP1095159A4 (en)	2003-01-02	Bone Morphogenetic Protein
EP1005544A4 (en)	2004-07-14	70 HUMAN, SECRETED PROTEINS
EP1019091A4 (en)	2005-05-11	50 SECRETED PROTEINS OF HUMAN ORIGIN
AP9901602A0 (en)	1999-09-30	Freeze-dried composition of bone morphogenetic protein human MP52
EP1027430A4 (en)	2001-09-19	SERIES OF 64 HUMAN SECRETED PROTEINS
EP1032838A4 (en)	2003-01-29	125 HUMAN SECRETED PROTEINS
AU7115996A (en)	1997-04-09	Uses of bone morphogenetic proteins
EP1009766A4 (en)	2003-04-09	19 HUMAN, SECRETED PROTEINS
EP1042674A4 (en)	2005-03-23	148 HUMAN SUCKED PROTEINS
EP1012262A4 (en)	2002-11-06	HFLP PROTEIN HFLP
EP1017707A4 (en)	2004-04-28	29 HUMAN SECRETED PROTEINS

Legal Events

Date	Code	Title
2007-07-06	KB	Patent renewed
2007-07-24	FF	Patent granted
2008-02-10	KB	Patent renewed